Global Hematopoietic Stem Cell Transplantation Market Report 2023: Forecast Market Size, Growth Rate And Key Drivers
27 Jul, 2023
The global hematopoietic stem cell transplantation market size is expected to grow from $3.88 billion in 2022 to $4.24 billion in 2023 at a compound annual growth rate (CAGR) of 9.27%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global hematopoietic stem cell transplantation market size is expected to reach $6.14 billion in 2027 at a CAGR of 9.70%.
Global Hematopoietic Stem Cell Transplantation Market Key Driver
The rising prevalence of blood cancer is predicted to drive the hematopoietic stem cell transplantation market forward. Blood cancers are a type of cancer that affects the growth and function of blood cells. The three main kinds of blood cancer are leukemia, lymphoma, and myeloma. Hematopoietic stem cell transplantation is commonly used to treat blood cancer by replacing stem cells and bone marrow cells that have been destroyed by the cancer. These newly formed stem cells can then go to the bone marrow and begin producing new blood cells. As a result of these reasons, the hematopoietic stem cell transplantation market is growing.
Get a sample of the global hematopoietic stem cell transplantation market reportGlobal Hematopoietic Stem Cell Transplantation Market Segments
The global hematopoietic stem cell transplantation market is segmented:
1) By Type: Allogeneic, Autologous
2) By Indication: Leukemia, Lymphatic Disorder, Myeloma, Other Non-Malignant Disorders
3) By Application: Bone Marrow Transplant, Peripheral Blood Stem Cell Transplant, Cord Blood Transplant
4) By End User: Hospital Pharmacy, Retail Pharmacy, Specialty Clinics
5) By Geography: The regions covered in the hematopoietic stem cell transplantation market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions, North America accounts for the largest share in the global hematopoietic stem cell transplantation market.
Major Hematopoietic Stem Cell Transplantation Industry Players
Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Cord Blood Corporation, Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories Inc., BiolineRx
Get the full global hematopoietic stem cell transplantation market report
Hematopoietic Stem Cell Transplantation Market Overview
Hematopoietic stem cell transplantation (HSCT) refers to the process of a medical procedure that is used to treat various blood and bone marrow disorders, such as certain genetic disorders and autoimmune diseases. The procedure involves replacing a patient's damaged or diseased bone marrow with healthy stem cells from a donor, which then grow and produce new blood cells in the patient's body. These stem cells can be obtained from bone marrow, peripheral blood, or umbilical cord blood.
Hematopoietic Stem Cell Transplantation Global Market Report 2023 provides data on the global hematopoietic stem cell transplantation market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The hematopoietic stem cell transplantation market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.